BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 21864868)

  • 1. Improvement in insulin sensitivity following a 1-year lifestyle intervention program in viscerally obese men: contribution of abdominal adiposity.
    Borel AL; Nazare JA; Smith J; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP
    Metabolism; 2012 Feb; 61(2):262-72. PubMed ID: 21864868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program.
    Borel AL; Nazare JA; Smith J; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP
    Obesity (Silver Spring); 2012 Jun; 20(6):1223-33. PubMed ID: 22262155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiometabolic risk improvement in response to a 3-yr lifestyle modification program in men: contribution of improved cardiorespiratory fitness vs. weight loss.
    Borel AL; Nazare JA; Baillot A; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP
    Am J Physiol Endocrinol Metab; 2017 Apr; 312(4):E273-E281. PubMed ID: 28028035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of obesity indices, metabolic parameters and age on cardiac autonomic function in abdominally obese men.
    Poliakova N; Després JP; Bergeron J; Alméras N; Tremblay A; Poirier P
    Metabolism; 2012 Sep; 61(9):1270-9. PubMed ID: 22444779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved plasma FFA/insulin homeostasis is independently associated with improved glucose tolerance after a 1-year lifestyle intervention in viscerally obese men.
    Borel AL; Boulet G; Nazare JA; Smith J; Alméras N; Tremblay A; Bergeron J; Poirier P; Carpentier AC; Després JP
    Diabetes Care; 2013 Oct; 36(10):3254-61. PubMed ID: 23695818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of body fat distribution by waist circumference, dual-energy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and non-obese postmenopausal women.
    dos Santos RE; Aldrighi JM; Lanz JR; Ferezin PC; Marone MM
    Gynecol Endocrinol; 2005 Nov; 21(5):295-301. PubMed ID: 16373250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the Bertin index to estimate visceral adipose tissue from dual-energy X-ray absorptiometry and cardiometabolic risk factors before and after weight loss.
    Karelis AD; Rabasa-Lhoret R; Pompilus R; Messier V; Strychar I; Brochu M; Aubertin-Leheudre M
    Obesity (Silver Spring); 2012 Apr; 20(4):886-90. PubMed ID: 21869764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalization of visceral adiposity is required to normalize plasma apolipoprotein B levels in response to a healthy eating/physical activity lifestyle modification program in viscerally obese men.
    Pelletier-Beaumont E; Arsenault BJ; Alméras N; Bergeron J; Tremblay A; Poirier P; Després JP
    Atherosclerosis; 2012 Apr; 221(2):577-82. PubMed ID: 22321874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin sensitivity deteriorates after short-term lifestyle intervention in the insulin sensitive phenotype of obesity.
    Gilardini L; Vallone L; Cottafava R; Redaelli G; Croci M; Conti A; Pasqualinotto L; Invitti C
    Obes Facts; 2012; 5(1):68-76. PubMed ID: 22433619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of extended hyperinsulinemic euglycemic clamp in the assessment of insulin sensitivity in obese individuals with glucose intolerance].
    Bao YQ; Jia WP; Chen L; Lu JX; Zhu M; Lu W; Xiang KA
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):740-4. PubMed ID: 17260458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
    Engelson ES; Agin D; Kenya S; Werber-Zion G; Luty B; Albu JB; Kotler DP
    Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of ectopic fat accumulation in liver and pancreas in obese men and women.
    Rossi AP; Fantin F; Zamboni GA; Mazzali G; Rinaldi CA; Del Giglio M; Di Francesco V; Barillari M; Pozzi Mucelli R; Zamboni M
    Obesity (Silver Spring); 2011 Sep; 19(9):1747-54. PubMed ID: 21593811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep apnoea attenuates the effects of a lifestyle intervention programme in men with visceral obesity.
    Borel AL; Leblanc X; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP; Series F
    Thorax; 2012 Aug; 67(8):735-41. PubMed ID: 22396182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waist circumference, dual-energy X-ray absortiometrically measured abdominal adiposity, and computed tomographically derived intra-abdominal fat area on detecting metabolic risk factors in obese women.
    Lee K; Lee S; Kim YJ; Kim YJ
    Nutrition; 2008; 24(7-8):625-31. PubMed ID: 18485667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a threshold of visceral fat loss that improves the metabolic profile in obese postmenopausal women?
    Brochu M; Tchernof A; Turner AN; Ades PA; Poehlman ET
    Metabolism; 2003 May; 52(5):599-604. PubMed ID: 12759890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in both global diet quality and physical activity level synergistically reduce visceral adiposity in men with features of metabolic syndrome.
    Nazare JA; Smith J; Borel AL; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP
    J Nutr; 2013 Jul; 143(7):1074-83. PubMed ID: 23719226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCSK9 levels in abdominally obese men: association with cardiometabolic risk profile and effects of a one-year lifestyle modification program.
    Arsenault BJ; Pelletier-Beaumont E; Alméras N; Tremblay A; Poirier P; Bergeron J; Després JP
    Atherosclerosis; 2014 Oct; 236(2):321-6. PubMed ID: 25128757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral obesity, impaired glucose tolerance, metabolic syndrome, and growth hormone therapy.
    Attallah H; Friedlander AL; Hoffman AR
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S62-7. PubMed ID: 16624603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contributions of cardiorespiratory fitness and visceral adiposity to six-year changes in cardiometabolic risk markers in apparently healthy men and women.
    Rhéaume C; Arsenault BJ; Dumas MP; Pérusse L; Tremblay A; Bouchard C; Poirier P; Després JP
    J Clin Endocrinol Metab; 2011 May; 96(5):1462-8. PubMed ID: 21325457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between several insulin sensitivity indices and metabolic risk factors in overweight and obese postmenopausal women: a MONET study.
    Malita FM; Messier V; Lavoie JM; Bastard JP; Rabasa-Lhoret R; Karelis AD
    Nutr Metab Cardiovasc Dis; 2010 Mar; 20(3):173-9. PubMed ID: 19501492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.